28 results on '"Hirschtritt, Matthew E."'
Search Results
2. Agreement between Youth Self-Report and Biospecimen-Confirmed Substance Use: A Systematic Review.
- Author
-
Folk, Johanna B., Hirschtritt, Matthew E., McCrary, Quincy D., and Kalapatapu, Raj K.
- Subjects
- *
ONLINE information services , *SUBSTANCE abuse , *BIOLOGICAL products , *MEDICAL information storage & retrieval systems , *SELF-evaluation , *SYSTEMATIC reviews , *AMPHETAMINES , *HAIR , *MEDLINE , *URINALYSIS , *METABOLITES - Abstract
Context Biospecimen analysis may enhance confidence in the accuracy of self-reported substance use among adolescents and transitional age youth (TAY). Associations between biospecimen types and self-reported use, however, are poorly characterized in the existing literature. Objective: We performed a systematic review of associations between biospecimen-confirmed and self-reported substance use. Data sources: PubMed, Embase, and Web of Science. Study selection: We included studies documenting associations between self-reported and biospecimen-confirmed substance use among adolescents (12–18 years) and TAY (19–26 years) published 1990–2020. Data extraction: Three authors extracted relevant data using a template and assessed bias risk using a modified JBI Critical Appraisal Tool. Results: We screened 1523 titles and abstracts, evaluated 73 full texts for eligibility, and included 28 studies. Most studies examined urine (71.4%) and hair (32.1%) samples. Self-report retrospective recall period varied from past 24 h to lifetime use. Agreement between self-report and biospecimen results were low to moderate and were higher with rapidly metabolized substances (e.g., amphetamines) and when shorter retrospective recall periods were applied. Frequently encountered sources of potential bias included use of non-validated self-report measures and failure to account for confounding factors in the association between self-reported and biospecimen-confirmed use. Limitations: Study heterogeneity prevented a quantitative meta-analysis. Studies varied in retrospective recall periods, biospecimen processing, and use of validated self-report measures. Conclusions: Associations between self-reported and biospecimen-confirmed substance use are low to moderate and are higher for shorter recall periods and for substances with rapid metabolism. Future studies should employ validated self-report measures and include demographically diverse samples. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Cannabis Use Among Patients With Psychotic Disorders.
- Author
-
Hirschtritt, Matthew E., Young-Wolff, Kelly C., Mathalon, Daniel H., and Satre, Derek D.
- Subjects
- *
PSYCHOSES , *MARIJUANA , *PRIMARY care , *TREATMENT effectiveness , *PATIENT compliance - Abstract
Amidst a rapidly changing legal landscape, cannabis use in the United States has become increasingly common in the past several years. There is strong evidence to suggest that chronic and early cannabis use increases the risk of developing a psychotic disorder, and there is at least moderate evidence that suggests ongoing cannabis use among individuals with a psychotic disorder worsens clinical outcomes (eg, decreased psychiatric medication adherence, more frequent psychiatric hospitalizations). In this Review Article, we provide a focused, clinically oriented overview of the epidemiology and characteristics of cannabis use among individuals with first-episode psychosis; evaluation of cannabis use; and treatment modalities, focusing on behavioral interventions suitable for outpatient primary care settings. We discuss the limited data supporting pharmacologic interventions for cannabis use disorder, specifically among individuals with first-episode psychosis, and the unique potential of cannabidiol to serve as a harm-reduction strategy for individuals who are not able or willing to achieve abstinence for cannabis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment.
- Author
-
Hirschtritt, Matthew E., Bloch, Michael H., and Mathews, Carol A.
- Subjects
- *
DIAGNOSIS of obsessive-compulsive disorder , *ANTIPSYCHOTIC agents , *SEROTONIN uptake inhibitors , *OBSESSIVE-compulsive disorder , *CLASSIFICATION of mental disorders , *DEEP brain stimulation , *THERAPEUTICS - Abstract
Importance: Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder associated with significant impairment and a lifetime prevalence of 1% to 3%; however, it is often missed in primary care settings and frequently undertreated.Objective: To review the most current data regarding screening, diagnosis, and treatment options for OCD.Evidence Review: We searched PubMed, EMBASE, and PsycINFO to identify randomized controlled trials (RCTs), meta-analyses, and systematic reviews that addressed screening and diagnostic and treatment approaches for OCD among adults (≥18 years), published between January 1, 2011, and September 30, 2016. We subsequently searched references of retrieved articles for additional reports. Meta-analyses and systematic reviews were prioritized; case series and reports were included only for interventions for which RCTs were not available.Findings: Among 792 unique articles identified, 27 (11 RCTs, 11 systematic reviews or meta-analyses, and 5 reviews/guidelines) were selected for this review. The diagnosis of OCD was revised for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, which addresses OCD separately from anxiety disorders and contains specifiers to delineate the presence of tics and degree of insight. Treatment advances include increasing evidence to support the efficacy of online-based dissemination of cognitive behavioral therapies, which have demonstrated clinically significant decreases in OCD symptoms when conducted by trained therapists. Current evidence continues to support the use of selective serotonin reuptake inhibitors as first-line pharmacologic interventions for OCD; however, more recent data support the adjunctive use of neuroleptics, deep-brain stimulation, and neurosurgical ablation for treatment-resistant OCD. Preliminary data suggest safety of other agents (eg, riluzole, ketamine, memantine, N-acetylcysteine, lamotrigine, celecoxib, ondansetron) either in combination with selective serotonin reuptake inhibitors or as monotherapy in the treatment of OCD, although their efficacy has not yet been established.Conclusions and Relevance: The dissemination of computer-based cognitive behavioral therapy and improved evidence supporting it represent a major advancement in treatment of OCD. Although cognitive behavioral therapy with or without selective serotonin reuptake inhibitors remains a preferred initial treatment strategy, increasing evidence that supports the safety and efficacy of neuroleptics and neuromodulatory approaches in treatment-resistant cases provides alternatives for patients whose condition does not respond to first-line interventions. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
5. Identification of Two Heritable Cross-Disorder Endophenotypes for Tourette Syndrome.
- Author
-
Darrow, Sabrina M., Hirschtritt, Matthew E., Davis, Lea K., Illmann, Cornelia, Osiecki, Lisa, Grados, Marco, Sandor, Paul, Dion, Yves, King, Robert, Pauls, David, Budman, Cathy L., Cath, Danielle C., Greenberg, Erica, Lyon, Gholson J., Yu, Dongmei, McGrath, Lauren M., McMahon, William M., Lee, Paul C., Delucchi, Kevin L., and Scharf, Jeremiah M.
- Subjects
- *
TOURETTE syndrome , *HUMAN phenotype , *SYMPTOMS , *MEDICAL genetics , *EXPLORATORY factor analysis , *GENETICS , *DIAGNOSIS of obsessive-compulsive disorder , *CHILDREN of people with mental illness , *ATTENTION-deficit hyperactivity disorder , *DISEASE susceptibility , *PSYCHOLOGY of mothers , *OBSESSIVE-compulsive disorder , *RESEARCH funding , *RISK assessment , *PHENOTYPES , *COMORBIDITY , *SEQUENCE analysis , *PSYCHOLOGICAL factors , *PSYCHOLOGY , *DIAGNOSIS - Abstract
Objective: Phenotypic heterogeneity in Tourette syndrome is partly due to complex genetic relationships among Tourette syndrome, obsessive-compulsive disorder (OCD), and attention deficit hyperactivity disorder (ADHD). Identifying symptom-based endophenotypes across diagnoses may aid gene-finding efforts.Method: Assessments for Tourette syndrome, OCD, and ADHD symptoms were conducted in a discovery sample of 3,494 individuals recruited for genetic studies. Symptom-level factor and latent class analyses were conducted in Tourette syndrome families and replicated in an independent sample of 882 individuals. Classes were characterized by comorbidity rates and proportion of parents included. Heritability and polygenic load associated with Tourette syndrome, OCD, and ADHD were estimated.Results: The authors identified two cross-disorder symptom-based phenotypes across analyses: symmetry (symmetry, evening up, checking obsessions; ordering, arranging, counting, writing-rewriting compulsions, repetitive writing tics) and disinhibition (uttering syllables/words, echolalia/palilalia, coprolalia/copropraxia, and obsessive urges to offend/mutilate/be destructive). Heritability estimates for both endophenotypes were high and statistically significant (disinhibition factor=0.35, SE=0.03; symmetry factor=0.39, SE=0.03; symmetry class=0.38, SE=0.10). Mothers of Tourette syndrome probands had high rates of symmetry (49%) but not disinhibition (5%). Polygenic risk scores derived from a Tourette syndrome genome-wide association study (GWAS) were significantly associated with symmetry, while risk scores derived from an OCD GWAS were not. OCD polygenic risk scores were significantly associated with disinhibition, while Tourette syndrome and ADHD risk scores were not.Conclusions: The analyses identified two heritable endophenotypes related to Tourette syndrome that cross traditional diagnostic boundaries. The symmetry phenotype correlated with Tourette syndrome polygenic load and was present in otherwise Tourette-unaffected mothers, suggesting that this phenotype may reflect additional Tourette syndrome (rather than OCD) genetic liability that is not captured by traditional DSM-based diagnoses. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
6. Using Neuroscience to Make Sense of Psychopathy.
- Author
-
Hirschtritt, Matthew E., Carroll, Joshua D., and Ross, David A.
- Subjects
- *
NEUROSCIENCES , *SHORT-term memory , *COGNITIVE ability , *PEOPLE with schizophrenia , *PSYCHOPATHY - Published
- 2018
- Full Text
- View/download PDF
7. Risks and Benefits of Benzodiazepines-Reply.
- Author
-
Hirschtritt, Matthew E., Olfson, Mark, and Kroenke, Kurt
- Subjects
- *
BENZODIAZEPINES , *MEDICATION safety , *DRUG utilization , *ATTITUDE (Psychology) , *MEDICAL personnel , *RISK assessment , *TRANQUILIZING drugs - Published
- 2021
- Full Text
- View/download PDF
8. Balancing the Risks and Benefits of Benzodiazepines.
- Author
-
Hirschtritt, Matthew E., Olfson, Mark, and Kroenke, Kurt
- Abstract
Following a September 2020 FDA announcement of a boxed warning for benzodiazepines, this Viewpoint reviews the relative benefits and risks of the drugs to reduce overuse in at-risk patients, moderate underuse in clinically appropriate instances, and guide judicious, rational prescribing. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders
- Author
-
Hirschtritt, Matthew E., Pagano, Maria E., Christian, Kelly M., McNamara, Nora K., Stansbrey, Robert J., Lingler, Jacqui, Faber, Jon E., Demeter, Christine A., Bedoya, Denise, and Findling, Robert L.
- Subjects
- *
FLUOXETINE , *COMORBIDITY , *SUBSTANCE abuse treatment , *RANDOMIZED controlled trials , *ANTIDEPRESSANTS , *MENTAL depression , *SYMPTOMS , *HOPELESSNESS theory of depression - Abstract
Abstract: Our recent 8-week, randomized, placebo-controlled trial of fluoxetine in adolescents (ages 12-17 years) with comorbid depression and substance use disorder (SUD) did not detect a significant antidepressant treatment effect. The purpose of this secondary analysis was to explore moderators of the effect of fluoxetine in this sample. Static moderators measured at baseline were depression chronicity and hopelessness severity; time-varying moderators measured at baseline and weekly during the 8-week trial period were alcohol and marijuana use severity. Treatment effects on depression outcomes were examined among moderating subgroups in random effects regression models. Subjects assigned to fluoxetine treatment with chronic depression at baseline (p = .04) or no more than moderate alcohol use during the trial (p = .04) showed significantly greater decline in depression symptoms in comparison to placebo-assigned subgroups. The current analysis suggests that youth with chronic depression and no more than moderate alcohol consumption are likely to respond better to treatment with fluoxetine compared with placebo than youth with transient depression and heavy alcohol use. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
10. Symptom-Specific Rating Scales in Child and Adolescent Psychiatry Clinical Practice.
- Author
-
Hirschtritt, Matthew E. and Bedoya, Denise
- Subjects
- *
PSYCHIATRIC drugs , *PSYCHIATRIC diagnosis , *PSYCHIATRIC rating scales , *DEPRESSION in adolescence , *GENERALIZED anxiety disorder , *BIPOLAR disorder in adolescence - Abstract
The article describes symptom-specific scales commonly referenced by practitioners who prescribe psychotropic medications to youths presenting with psychiatric conditions. The Children's Depression Rating Scale-Revised is cited as the most commonly utilized scale for measuring depression severity in clinical trials of psychotropic medications. For generalized anxiety, the Pediatric Anxiety Rating Scale is commonly used. The Young Mania Rating Scale is used when dealing with bipolar disorder.
- Published
- 2011
- Full Text
- View/download PDF
11. Focus: The Use of Rating Scales to Track Therapeutic Progress: General Rating scales in Child and Adolescent Psychiatry Clinical Practice.
- Author
-
Hirschtritt, Matthew E. and Bedoya, Denise
- Subjects
- *
PSYCHIATRIC rating scales , *PERSONALITY assessment , *BEHAVIORAL assessment , *MENTAL illness treatment -- Evaluation , *PSYCHOMETRICS - Abstract
The article describes important psychometric properties of psychiatric rating scales. It discusses the three scales such as the Achenbach System of Empirically Based Assessment (ASEBA), the Behavior Assessment System for Children--Second Edition (BASC-2) and Strengths and Difficulties Questionnaire (SDQ). It also compares the ASEBA and the BASC-2.
- Published
- 2010
- Full Text
- View/download PDF
12. Focus: The Use of Rating Scales to Track Therapeutic Progress: Overview of Rating Scales in Child and Adolescent Psychiatry Clinical Practice.
- Author
-
Hirschtritt, Matthew E. and Bedoya, Denise
- Subjects
- *
PSYCHIATRIC rating scales , *MENTAL illness treatment -- Evaluation , *ADOLESCENT psychiatry , *CHILD psychiatry , *PERSONALITY assessment , *BEHAVIORAL assessment - Abstract
The article discusses the use of rating scales in child and adolescent psychiatry clinical practice. The use the right rating scale in the practice can reportedly help bypass visit-to-visit variability in information ascertainment inherent in unstructured interview. Rating scales, the author notes, may help streamline the clinical evaluation process of patients when used correctly. The scores from the rating scales can be compared from baseline to multiple time points throughout treatment to monitor the effectiveness of treatment.
- Published
- 2010
- Full Text
- View/download PDF
13. Improving Usability of Health Information Technology.
- Author
-
Hirschtritt, Matthew E. and Hirschtritt, Deirdre B.
- Subjects
- *
HEALTH information technology , *ELECTRONIC health records , *MEDICAL technology , *INFORMATION storage & retrieval systems , *MEDICAL databases , *MANAGEMENT of electronic health records - Abstract
The article comments on a report on the challenges in the usability of health information technology (HIT) and potential ways to improve the design of electronic health records (EHR). Topics discussed include the need to consider clinicians and patients who interact with EHR when creating a user-friendly design, EHR design not considering user disabilities and medical students' request for accommodations for various disabilities and barriers to their use of EHR.
- Published
- 2019
- Full Text
- View/download PDF
14. Preparing Physician-Scientists for an Evolving Research Ecosystem.
- Author
-
Hirschtritt, Matthew E., Heaton, Penny M., and Insel, Thomas R.
- Subjects
- *
PHYSICIANS , *PUBLIC-private sector cooperation , *VOCATIONAL guidance , *SCIENTISTS , *MEDICAL research & economics , *EDUCATION of research personnel , *ENDOWMENT of research , *MEDICAL education , *MEDICAL research , *INSTITUTIONAL cooperation - Abstract
In this Viewpoint, Insel and colleagues discuss the roles that private sector companies and foundations might play and the advantages of public-private partnerships in nurturing new and early-career physician-investigators given an always-challenging funding environment and ever-increasing hurdles young physicians must overcome to establish a research career. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
15. Screening for Depression.
- Author
-
Hirschtritt, Matthew E. and Kroenke, Kurt
- Subjects
- *
DEPRESSION in men , *MEDICAL screening , *DIAGNOSIS of mental depression , *BEREAVEMENT , *PHYSICIAN-patient relations , *INSOMNIA , *DEPRESSED persons , *QUESTIONNAIRES , *MEDICAL care - Abstract
The article presents a case study involving a 57-year-old male patient who presented to his physicians with mental depression and insomnia, and it mentions the use of medical screening techniques to diagnose depression. According to the article, the patient has been dealing with increased hopelessness and insomnia in the aftermath of his husband's death. The Patient Health Questionnaire 9 (PHQ-9) is examined, along with depressive symptoms and anxiety.
- Published
- 2017
- Full Text
- View/download PDF
16. Interrupting the Mental Illness-Incarceration-Recidivism Cycle.
- Author
-
Hirschtritt, Matthew E. and Binder, Renee L.
- Subjects
- *
LEGAL status of criminals with mental illness , *IMPRISONMENT , *COMMUNITY mental health services , *RECIDIVISM rates , *CRIMINAL justice system , *PEOPLE with mental illness , *CARE of people , *PEOPLE with schizophrenia , *PRISONS , *STATUS (Law) - Abstract
The article discusses the authors' views about methods for reducing the flow of individuals with serious mental illness into America's criminal justice system, and it mentions the claim that patients with schizophrenia, major depressive disorders, and bipolar disorder are being disproportionately incarcerated in U.S. jails and prisons instead of community-based mental health clinics. Recidivism rates and decriminalization are examined, along with mental health treatment engagement.
- Published
- 2017
- Full Text
- View/download PDF
17. Deep Brain Stimulation for Obsessive-Compulsive Disorder-Reply.
- Author
-
Hirschtritt, Matthew E., Bloch, Michael H., and Mathews, Carol A.
- Subjects
- *
DEEP brain stimulation , *MENTAL health services , *OBSESSIVE-compulsive disorder , *COGNITIVE therapy - Published
- 2017
- Full Text
- View/download PDF
18. Psychiatric Pharmacogenomics: How Close Are We?
- Author
-
Hirschtritt, Matthew E., Besterman, Aaron D., and Ross, David A.
- Subjects
- *
MENTAL illness treatment , *PHARMACOGENOMICS , *DRUG efficacy , *DRUG toxicity , *PSYCHIATRIC drugs - Published
- 2016
- Full Text
- View/download PDF
19. Burnout Among Psychiatry Residents and One Program’s Approach to Creating a Culture of Wellness.
- Author
-
Brown, Kathryn H., Bal, Berneen, Plauche, Jessica L., Sung, Dawn, and Hirschtritt, Matthew E.
- Subjects
- *
MENTAL health services , *PSYCHIATRY , *PSYCHOLOGICAL burnout , *SECONDARY traumatic stress , *VIOLENCE in the workplace - Abstract
Psychiatry residency training includes unique characteristics that can predispose trainees to burnout, including vicarious traumatization, prevalence of patient suicide and violence in the workplace, and social stigma surrounding mental health. For the purposes of this article, the authors examine these contributing factors and address how psychiatry residency training programs, specifically the Kaiser Permanente Oakland program, are responding to these unique challenges with wellness initiatives. Initiatives to promote wellness at Kaiser Permanente Oakland include a resident and faculty–led wellness committee, work-hour limits, reasonable call schedules, a robust mentorship program, funded social and networking events programs, and comprehensive mental health services. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Patient and Visit Characteristics Associated With Physical Restraint Use in the Emergency Department.
- Author
-
Walia, Harbir, Tucker, Lue-Yen S., Manickam, Raj N., Kene, Mamata V., Sharp, Adam L., Berdahl, Carl T., and Hirschtritt, Matthew E.
- Subjects
- *
RESTRAINT of patients , *HOSPITAL emergency services , *ELECTRONIC health records - Abstract
OBJECTIVE: Physical restraints are used in emergency departments (EDs) to address behavioral emergencies in situations in which less restrictive methods have failed. The objective of this study was to evaluate for associations between patient/visit characteristics and physical restraint use. STUDY DESIGN: This study was designed as a cross-sectional, retrospective study of all encounters at Kaiser Permanente Northern California EDs from January 1, 2016, to December 31, 2019, to evaluate differences in patient and visit characteristics between visits involving physical restraint use and those without. METHODS: Using electronic health record data, this study identified physical restraint use among ED encounters and extracted demographic, clinical, and facility characteristics. The authors calculated odds ratios for physical restraint placement, adjusting for patient and visit characteristics and accounting for within-patient clustering. RESULTS: Among 4,410,816 encounters (representing 1,791,673 patients), 6369 encounters (0.1%) involved physical restraint use among 5,554 patients (0.3%). Variables associated with the lowest odds of physical restraint included female sex, presentation to the ED in more recent years, and presence of intentional self-harm/suicidal ideation. Variables associated with the highest odds of physical restraint included higher visit acuity and weekend presentations to the ED. DISCUSSION: This study, which leveraged a large, diverse patient sample generalizable to the Northern California population, found several patient and visit characteristics associated with physical restraint use in the ED. CONCLUSION: Results of this study may help identify patient groups and situational factors that are most likely to lead to physical restraint use and structural factors contributing to disparities in care, thereby informing interventions to reduce physical restraint use when possible. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Cost-Effectiveness of Motivational Interviewing to Reduce Alcohol and Cannabis Use Among Patients With Depression.
- Author
-
Satre, Derek D, Parthasarathy, Sujaya, Young-Wolff, Kelly C, Meacham, Meredith C, Borsari, Brian, Hirschtritt, Matthew E, Van Dyke, Lucas, and Sterling, Stacy A
- Abstract
Objective: Motivational interviewing (MI) is a promising intervention for helping patients with mental health problems reduce their substance use. Examining the cost-effectiveness of MI and associations between MI and the use of health services can inform appropriate intervention strategies for these patients.Method: Kaiser Permanente adult patients with depression symptoms (Patient Health Questionnaire [PHQ-9] score > 5) seen in outpatient psychiatry (N = 302) who reported unhealthy alcohol use or other substance use (primarily cannabis) were randomized to three sessions of MI (intervention) or printed literature (control) with telephone follow-up interviews at 6 and 12 months. Cost-effectiveness analyses compared intervention costs associated with 30-day abstinence from unhealthy alcohol use (i.e., any days of ≥4/≥5 drinks for women/men) and cannabis use. Multivariable analyses examined associations between MI and healthcare utilization at 12 months (emergency department, primary care, psychiatry, and addiction treatment).Results: MI resulted in greater likelihood of abstaining from unhealthy alcohol use (70.0% vs. 60.2%, p < .01) and cannabis use (74.6% vs. 63.9%, p < .01) than the control at 6 months, but outcomes did not differ at 12 months. The 6-month incremental cost-effectiveness ratios were $1,207-$1,523 per abstinent patient for unhealthy drinking and $1,040-$1,313 per abstinent patient for cannabis. There were no differences between groups on health service utilization.Conclusions: MI cost more than the control condition but yielded better outcomes at 6 months; MI had no relationship to health service utilization. Findings can inform implementation of substance use interventions through understanding MI's potential clinical and cost impact and its relationship to health services use. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
22. Cost-Effectiveness of Motivational Interviewing to Reduce Alcohol and Cannabis Use Among Patients With Depression.
- Author
-
Satre, Derek D., Parthasarathy, Sujaya, Young-Wolff, Kelly C., Meacham, Meredith C., Borsari, Brian, Hirschtritt, Matthew E., Van Dyke, Lucas, and Sterling, Stacy A.
- Abstract
Objective: Motivational interviewing (MI) is a promising intervention for helping patients with mental health problems reduce their substance use. Examining the cost-effectiveness of MI and associations between MI and the use of health services can inform appropriate intervention strategies for these patients. Method: Kaiser Permanente adult patients with depression symptoms (Patient Health Questionnaire [PHQ-9] score > 5) seen in outpatient psychiatry (N = 302) who reported unhealthy alcohol use or other substance use (primarily cannabis) were randomized to three sessions of MI (intervention) or printed literature (control) with telephone follow-up interviews at 6 and 12 months. Cost-effectiveness analyses compared intervention costs associated with 30-day abstinence from unhealthy alcohol use (i.e., any days of ≥4/≥5 drinks for women/men) and cannabis use. Multivariable analyses examined associations between MI and healthcare utilization at 12 months (emergency department, primary care, psychiatry, and addiction treatment). Results: MI resulted in greater likelihood of abstaining from unhealthy alcohol use (70.0% vs. 60.2%, p < .01) and cannabis use (74.6% vs. 63.9%, p < .01) than the control at 6 months, but outcomes did not differ at 12 months. The 6-month incremental cost-effectiveness ratios were $1,207-$1,523 per abstinent patient for unhealthy drinking and $1,040-$1,313 per abstinent patient for cannabis. There were no differences between groups on health service utilization. Conclusions: MI cost more than the control condition but yielded better outcomes at 6 months; MI had no relationship to health service utilization. Findings can inform implementation of substance use interventions through understanding MI's potential clinical and cost impact and its relationship to health services use. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. Is Persistent Motor or Vocal Tic Disorder a Milder Form of Tourette Syndrome?
- Author
-
Claudio‐Campos, Karla, Stevens, Daniel, Koo, Sang‐Wahn, Valko, Alexa, Bienvenu, Oscar Joseph, Budman, Cathy B., Cath, Danielle C., Darrow, Sabrina, Geller, Daniel, Goes, Fernando S., Grados, Marco A., Greenberg, Benjamin D., Greenberg, Erica, Hirschtritt, Matthew E., Illmann, Cornelia, Ivankovic, Franjo, King, Robert A., Knowles, James A., Krasnow, Janice, and Lee, Paul C.
- Abstract
Background: Persistent motor or vocal tic disorder (PMVT) has been hypothesized to be a forme fruste of Tourette syndrome (TS). Although the primary diagnostic criterion for PMVT (presence of motor or vocal tics, but not both) is clear, less is known about its clinical presentation. Objective: The goals of this study were to compare the prevalence and number of comorbid psychiatric disorders, tic severity, age at tic onset, and family history for TS and PMVT. Methods: We analyzed data from two independent cohorts using generalized linear equations and confirmed our findings using meta‐analyses, incorporating data from previously published literature. Results: Rates of obsessive–compulsive disorder (OCD) and attention deficit hyperactivity disorder (ADHD) were lower in PMVT than in TS in all analyses. Other psychiatric comorbidities occurred with similar frequencies in PMVT and TS in both cohorts, although meta‐analyses suggested lower rates of most psychiatric disorders in PMVT compared with TS. ADHD and OCD increased the odds of comorbid mood, anxiety, substance use, and disruptive behaviors, and accounted for observed differences between PMVT and TS. Age of tic onset was approximately 2 years later, and tic severity was lower in PMVT than in TS. First‐degree relatives had elevated rates of TS, PMVT, OCD, and ADHD compared with population prevalences, with rates of TS equal to or greater than PMVT rates. Conclusions: Our findings support the hypothesis that PMVT and TS occur along a clinical spectrum in which TS is a more severe and PMVT a less severe manifestation of a continuous neurodevelopmental tic spectrum disorder. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies.
- Author
-
Yu, Dongmei, Sul, Jae Hoon, Tsetsos, Fotis, Nawaz, Muhammad S., Huang, Alden Y., Zelaya, Ivette, Illmann, Cornelia, Osiecki, Lisa, Darrow, Sabrina M., Hirschtritt, Matthew E., Greenberg, Erica, Muller-Vahl, Kirsten R., Stuhrmann, Manfred, Dion, Yves, Rouleau, Guy, Aschauer, Harald, Stamenkovic, Mara, Schlögelhofer, Monika, Sandor, Paul, and Barr, Cathy L.
- Subjects
- *
LOCUS (Genetics) - Abstract
Objective: Tourette's syndrome is polygenic and highly heritable. Genome-wide association study (GWAS) approaches are useful for interrogating the genetic architecture and determinants of Tourette's syndrome and other tic disorders. The authors conducted a GWAS meta-analysis and probed aggregated Tourette's syndrome polygenic risk to test whether Tourette's and related tic disorders have an underlying shared genetic etiology and whether Tourette's polygenic risk scores correlate with worst-ever tic severity and may represent a potential predictor of disease severity.Methods: GWAS meta-analysis, gene-based association, and genetic enrichment analyses were conducted in 4,819 Tourette's syndrome case subjects and 9,488 control subjects. Replication of top loci was conducted in an independent population-based sample (706 case subjects, 6,068 control subjects). Relationships between Tourette's polygenic risk scores (PRSs), other tic disorders, ascertainment, and tic severity were examined.Results: GWAS and gene-based analyses identified one genome-wide significant locus within FLT3 on chromosome 13, rs2504235, although this association was not replicated in the population-based sample. Genetic variants spanning evolutionarily conserved regions significantly explained 92.4% of Tourette's syndrome heritability. Tourette's-associated genes were significantly preferentially expressed in dorsolateral prefrontal cortex. Tourette's PRS significantly predicted both Tourette's syndrome and tic spectrum disorders status in the population-based sample. Tourette's PRS also significantly correlated with worst-ever tic severity and was higher in case subjects with a family history of tics than in simplex case subjects.Conclusions: Modulation of gene expression through noncoding variants, particularly within cortico-striatal circuits, is implicated as a fundamental mechanism in Tourette's syndrome pathogenesis. At a genetic level, tic disorders represent a continuous spectrum of disease, supporting the unification of Tourette's syndrome and other tic disorders in future diagnostic schemata. Tourette's PRSs derived from sufficiently large samples may be useful in the future for predicting conversion of transient tics to chronic tic disorders, as well as tic persistence and lifetime tic severity. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
25. Prevalence and predictors of hair pulling disorder and excoriation disorder in Tourette syndrome.
- Author
-
Greenberg, Erica, Tung, Esther S., Gauvin, Caitlin, Osiecki, Lisa, Yang, Kelly G., Curley, Erin, Essa, Angela, Illmann, Cornelia, Sandor, Paul, Dion, Yves, Lyon, Gholson J., King, Robert A., Darrow, Sabrina, Hirschtritt, Matthew E., Budman, Cathy L., Grados, Marco, Pauls, David L., Keuthen, Nancy J., Mathews, Carol A., and Scharf, Jeremiah M.
- Subjects
- *
INTERVIEWING , *RESEARCH methodology , *OBSESSIVE-compulsive disorder , *SEX distribution , *TOURETTE syndrome , *COMPULSIVE hair pulling , *DISEASE prevalence , *COMPULSIVE skin picking - Abstract
Trichotillomania/hair pulling disorder (HPD) and excoriation/skin picking disorder (SPD) are childhood-onset, body-focused repetitive behaviors that are thought to share genetic susceptibility and underlying pathophysiology with obsessive-compulsive disorder (OCD) and Tourette syndrome (TS). We sought to determine the prevalence of
DSM -5 HPD and SPD in TS patients, and to identify clinical factors most associated with their co-morbidity with TS. Participants included 811 TS patients recruited from TS specialty clinics for a multi-center genetic study. Patients were assessed using standardized, validated semi-structured interviews. HPD and SPD diagnoses were determined using a validated self-report questionnaire. HPD/SPD prevalence rates were calculated, and clinical predictors were evaluated using regression modeling. 3.8 and 13.0% of TS patients metDSM -5 criteria for HPD and SPD, respectively. In univariable analyses, female sex, OCD, and both tic and obsessive-compulsive symptom severity were among those associated with HPD and/or SPD. In multivariable analyses, only lifetime worst-ever motor tic severity remained significantly associated with HPD. Female sex, co-occurring OCD, ADHD, and motor tic severity remained independently associated with SPD. This is the first study to examine HPD and SPD prevalence in a TS sample using semi-structured diagnostic instruments. The prevalence of HPD and SPD in TS patients, and their association with increased tic severity and co-occurring OCD, suggests that clinicians should screen children with TS and related disorders for HPD/SPD, particularly in females and in those with co-occurring OCD. This study also helps set a foundation for subsequent research regarding HPD/SPD risk factors, pathophysiology, and treatment models. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
26. Web-based phenotyping for Tourette Syndrome: Reliability of common co-morbid diagnoses.
- Author
-
Darrow, Sabrina M., Illmann, Cornelia, Gauvin, Caitlin, Osiecki, Lisa, Egan, Crystelle A., Greenberg, Erica, Eckfield, Monika, Hirschtritt, Matthew E., Pauls, David L., Batterson, James R., Berlin, Cheston M., Malaty, Irene A., Woods, Douglas W., Scharf, Jeremiah M., and Mathews, Carol A.
- Subjects
- *
TOURETTE syndrome , *PHENOTYPES , *COMORBIDITY , *NEUROBEHAVIORAL disorders , *INTERNET in medicine ,PSYCHIATRIC research - Abstract
Collecting phenotypic data necessary for genetic analyses of neuropsychiatric disorders is time consuming and costly. Development of web-based phenotype assessments would greatly improve the efficiency and cost-effectiveness of genetic research. However, evaluating the reliability of this approach compared to standard, in-depth clinical interviews is essential. The current study replicates and extends a preliminary report on the utility of a web-based screen for Tourette Syndrome (TS) and common comorbid diagnoses (obsessive compulsive disorder (OCD) and attention deficit/hyperactivity disorder (ADHD)). A subset of individuals who completed a web-based phenotyping assessment for a TS genetic study was invited to participate in semi-structured diagnostic clinical interviews. The data from these interviews were used to determine participants׳ diagnostic status for TS, OCD, and ADHD using best estimate procedures, which then served as the gold standard to compare diagnoses assigned using web-based screen data. The results show high rates of agreement for TS. Kappas for OCD and ADHD diagnoses were also high and together demonstrate the utility of this self-report data in comparison previous diagnoses from clinicians and dimensional assessment methods. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
27. Depolarizing bipolar cell dysfunction due to a Trpm1 point mutation.
- Author
-
Peachey, Neal S., Pearring, Jillian N., Bojang Jr., Pasano, Hirschtritt, Matthew E., Sturgill-Short, Gwen, Ray, Thomas A., Takahisa Furukawa, Chieko Koike, Goldberg, Andrew F. X., Yin Shen, McCall, Maureen A., Nawy, Scott, Nishina, Patsy M., and Gregg, Ronald G.
- Abstract
Mutations in TRPM1 are found in humans with an autosomal recessive form of complete congenital stationary night blindness (cCSNB). The Trpm1-/- mouse has been an important animal model for this condition. Here we report a new mouse mutant, tvrm27, identified in a chemical mutagenesis screen. Genetic mapping of the no b-wave electroretinogram (ERG) phenotype of tvrm27 localized the mutation to a chromosomal region that included Trpm1. Complementation testing with Trpm1-/- mice confirmed a mutation in Trpm1. Sequencing identified a nucleotide change in exon 23, converting a highly conserved alanine within the pore domain to threonine (p.A1068T). Consistent with prior studies of Trpm1-/- mice, no anatomical changes were noted in the Trpm1tvrm27/tvrm27 retina. The Trpm1tvrm27/tvrm27 phenotype is distinguished from that of Trpm1-/- by the retention of TRPM1 expression on the dendritic tips of depolarizing bipolar cells (DBCs). While ERG b-wave amplitudes of Trpm1+/- heterozygotes are comparable to wild type, those of Trpm1+/tvrm27 mice are reduced by 32%. A similar reduction in the response of Trpm1+/tvrm27 DBCs to LY341495 or capsaicin is evident in whole cell recordings. These data indicate that the p.A1068T mutant TRPM1 acts as a dominant negative with respect to TRPM1 channel function. Furthermore, these data indicate that the number of functional TRPM1 channels at the DBC dendritic tips is a key factor in defining DBC response amplitude. The Trpm1tvrm27/tvrm27 mutant will be useful for elucidating the role of TRPM1 in DBC signal transduction, for determining how Trpm1 mutations impact central visual processing, and for evaluating experimental therapies for cCSNB. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
28. Autism Spectrum Symptoms in a Tourette's Disorder Sample.
- Author
-
Darrow, Sabrina M., Grados, Marco, Sandor, Paul, Hirschtritt, Matthew E., Illmann, Cornelia, Osiecki, Lisa, Dion, Yves, King, Robert, Pauls, David, Budman, Cathy L., Cath, Danielle C., Greenberg, Erica, Lyon, Gholson J., McMahon, William M., Lee, Paul C., Delucchi, Kevin L., Scharf, Jeremiah M., and Mathews, Carol A.
- Subjects
- *
TOURETTE syndrome , *AUTISM spectrum disorders , *ATTENTION-deficit hyperactivity disorder , *HERITABILITY , *OBSESSIVE-compulsive disorder , *RESEARCH funding , *COMORBIDITY - Abstract
Objective: Tourette's disorder (TD) and autism spectrum disorder (ASD) share clinical features and possibly an overlapping etiology. The aims of this study were to examine ASD symptom rates in participants with TD, and to characterize the relationships between ASD symptom patterns and TD, obsessive-compulsive disorder (OCD), and attention-deficit/hyperactivity disorder (ADHD).Method: Participants with TD (n = 535) and their family members (n =234) recruited for genetic studies reported TD, OCD, and ADHD symptoms and completed the Social Responsiveness Scale Second Edition (SRS), which was used to characterize ASD symptoms.Results: SRS scores in participants with TD were similar to those observed in other clinical samples but lower than in ASD samples (mean SRS total raw score = 51; SD = 32.4). More children with TD met cut-off criteria for ASD (22.8%) than adults with TD (8.7%). The elevated rate in children was primarily due to high scores on the SRS Repetitive and Restricted Behaviors (RRB) subscale. Total SRS scores were correlated with TD (r = 0.27), OCD (r = 0.37), and ADHD (r = 0.44) and were higher among individuals with OCD symptom-based phenotypes than for those with tics alone.Conclusion: Higher observed rates of ASD among children affected by TD may in part be due to difficulty in discriminating complex tics and OCD symptoms from ASD symptoms. Careful examination of ASD-specific symptom patterns (social communication vs. repetitive behaviors) is essential. Independent of ASD, the SRS may be a useful tool for identifying patients with TD with impairments in social communication that potentially place them at risk for bullying and other negative sequelae. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.